MX385405B - Composición inyectable en el vítreo de un ojo que comprende un inhibidor de cinasa y el uso de la misma para tratar una enfermedad ocular. - Google Patents
Composición inyectable en el vítreo de un ojo que comprende un inhibidor de cinasa y el uso de la misma para tratar una enfermedad ocular.Info
- Publication number
- MX385405B MX385405B MX2017014084A MX2017014084A MX385405B MX 385405 B MX385405 B MX 385405B MX 2017014084 A MX2017014084 A MX 2017014084A MX 2017014084 A MX2017014084 A MX 2017014084A MX 385405 B MX385405 B MX 385405B
- Authority
- MX
- Mexico
- Prior art keywords
- eye
- vitreous
- treat
- kinase inhibitor
- injectable composition
- Prior art date
Links
- 229940043355 kinase inhibitor Drugs 0.000 title abstract 2
- 239000003757 phosphotransferase inhibitor Substances 0.000 title abstract 2
- 208000030533 eye disease Diseases 0.000 title 1
- 239000007972 injectable composition Substances 0.000 title 1
- 208000002780 macular degeneration Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 208000004644 retinal vein occlusion Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Quinoline Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562157257P | 2015-05-05 | 2015-05-05 | |
| PCT/US2016/030912 WO2016179357A1 (en) | 2015-05-05 | 2016-05-05 | Injectable depot formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017014084A MX2017014084A (es) | 2018-06-20 |
| MX385405B true MX385405B (es) | 2025-03-18 |
Family
ID=57218334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017014084A MX385405B (es) | 2015-05-05 | 2016-05-05 | Composición inyectable en el vítreo de un ojo que comprende un inhibidor de cinasa y el uso de la misma para tratar una enfermedad ocular. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20160324836A1 (enExample) |
| EP (1) | EP3291812B1 (enExample) |
| JP (1) | JP2018520093A (enExample) |
| CN (1) | CN107530334A (enExample) |
| AU (1) | AU2016258001B2 (enExample) |
| BR (1) | BR112017023762A2 (enExample) |
| CA (1) | CA2984637A1 (enExample) |
| MX (1) | MX385405B (enExample) |
| RU (1) | RU2017137763A (enExample) |
| WO (1) | WO2016179357A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107278151A (zh) | 2014-12-15 | 2017-10-20 | 约翰霍普金斯大学 | 舒尼替尼制剂及其在治疗青光眼中的使用方法 |
| BR112018009644A2 (pt) | 2015-11-12 | 2018-11-06 | Graybug Vision Inc | micropartículas agregantes sólidas modificadas na superfície, material injetável, processo para preparação de micropartículas agregantes sólidas modificadas na superfície, método para tratamento de um distúrbio ocular, e, uso de micropartículas agregantes sólidas modificadas na superfície |
| JP7217022B2 (ja) | 2017-03-23 | 2023-02-02 | グレイバグ ビジョン インコーポレイテッド | 眼障害の治療のための薬物及び組成物 |
| CA3057875A1 (en) | 2017-05-10 | 2018-11-15 | Graybug Vision, Inc. | Extended release microparticles and suspensions thereof for medical therapy |
| CN114245737A (zh) * | 2019-06-11 | 2022-03-25 | 司斐股份有限公司 | 微乳剂组合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2156834A1 (en) * | 2008-08-08 | 2010-02-24 | S.I.F.I - Società Industria Farmaceutica Italiana - S.P.A. | Ophthalmic pharmaceutical compositions comprising Sorafenib for the treatment of neoangiogenic pathologies of the eye |
| CN101890018B (zh) * | 2009-05-22 | 2014-06-18 | 中国科学院化学研究所 | 一种酪氨酸蛋白激酶抑制剂及其制备方法 |
| WO2013000909A1 (en) * | 2011-06-28 | 2013-01-03 | Bayer Intellectual Property Gmbh | Topical ophthalmological pharmaceutical composition containing sorafenib |
| CN104204804B (zh) * | 2011-11-11 | 2016-09-28 | 因特利凯有限责任公司 | 激酶抑制剂的组合及其用途 |
| AR089248A1 (es) * | 2011-12-14 | 2014-08-06 | Abbvie Inc | Composiciones que contienen inhibidores de quinasas |
-
2016
- 2016-05-05 US US15/147,198 patent/US20160324836A1/en not_active Abandoned
- 2016-05-05 JP JP2017558027A patent/JP2018520093A/ja active Pending
- 2016-05-05 AU AU2016258001A patent/AU2016258001B2/en active Active
- 2016-05-05 EP EP16790066.1A patent/EP3291812B1/en active Active
- 2016-05-05 CN CN201680025439.7A patent/CN107530334A/zh active Pending
- 2016-05-05 CA CA2984637A patent/CA2984637A1/en not_active Abandoned
- 2016-05-05 WO PCT/US2016/030912 patent/WO2016179357A1/en not_active Ceased
- 2016-05-05 RU RU2017137763A patent/RU2017137763A/ru not_active Application Discontinuation
- 2016-05-05 BR BR112017023762-8A patent/BR112017023762A2/pt not_active Application Discontinuation
- 2016-05-05 MX MX2017014084A patent/MX385405B/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2016258001B2 (en) | 2020-06-04 |
| WO2016179357A1 (en) | 2016-11-10 |
| EP3291812A4 (en) | 2019-01-09 |
| MX2017014084A (es) | 2018-06-20 |
| CA2984637A1 (en) | 2016-11-10 |
| US20160324836A1 (en) | 2016-11-10 |
| EP3291812B1 (en) | 2021-09-01 |
| CN107530334A (zh) | 2018-01-02 |
| BR112017023762A2 (pt) | 2018-07-31 |
| RU2017137763A (ru) | 2019-06-05 |
| EP3291812A1 (en) | 2018-03-14 |
| AU2016258001A1 (en) | 2017-11-09 |
| JP2018520093A (ja) | 2018-07-26 |
| RU2017137763A3 (enExample) | 2019-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017004715A2 (es) | Métodos y formulaciones para tratar enfermedades vasculares de los ojos | |
| MX2019007586A (es) | Composiciones que comprenden tacrolimus para el tratamiento de enfermedades inflamatorias intraoculares. | |
| MX2017016655A (es) | Formulaciones oftalmicas de inhibidores de tirosina quinasa, metodos de uso de las mismas y metodos de preparacion de las mismas. | |
| MX2020001340A (es) | Modelos celulares y terapias para enfermedades oculares. | |
| CO2017004525A2 (es) | Dihidropirrolopiridinas inhibidoras de ror-gamma | |
| MX2024007658A (es) | Composiciones y metodos de uso de nintedanib para mejorar el exito de la cirugia del glaucoma. | |
| EA201790398A1 (ru) | Способы лечения заболевания печени | |
| MX2021009673A (es) | Moduladores de ror-gamma. | |
| MX2017016517A (es) | Composiciones estables al almacenamiento y metodos para el tratamiento de errores de refraccion del ojo. | |
| HK1258588A1 (zh) | 用於治療眼科疾病的化合物和製劑 | |
| NI201600115A (es) | Derivados de sulfamoilpirrolamida y su uso como medicamentos para el tratamiento de la hepatitis b. | |
| MX2017002374A (es) | Composiciones y metodos para tratar trastornos de la vision. | |
| MX388380B (es) | Composiciones para usarse en el incremento de los niveles de glóbulos rojos y el tratamiento de enfermedad de células falciformes. | |
| CL2008001259A1 (es) | Uso de una composicion que comprende un inhibidor del factor d del complemento para preparar un medicamento util para la inhibicion de la perdida de agudeza visual ociada con la degeneracion macular relacionada con la edad. | |
| MX385405B (es) | Composición inyectable en el vítreo de un ojo que comprende un inhibidor de cinasa y el uso de la misma para tratar una enfermedad ocular. | |
| WO2016073771A3 (en) | Pyrrolopyrimidine derivatives as mps1/ttk kinase inhibitors | |
| MX2018012285A (es) | Metodos de tratamiento para enfermedades colestasicas y fibroticas. | |
| MX2016010215A (es) | Composiciones y metodos de tratamiento y prevencion de degeneracion macular. | |
| EA201692402A1 (ru) | Лекарственные формы для местного применения и их использование | |
| PH12016501371A1 (en) | Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same | |
| MX2017007000A (es) | Composiciones que comprenden acido 15-hidroxieicosapentaenoico (15-hepe) y metodos para tratar o prevenir la fibrosis usando las mismas. | |
| CL2019002839A1 (es) | Métodos y composiciones para tratar enfermedades asociadas a la retina mediante inhibidores de ccr3. | |
| MX2020012011A (es) | Conjugados y derivados de prostaglandina para tratar el glaucoma y la hipertension ocular. | |
| BR112016016901A2 (pt) | agentes para o uso no tratamento de inflamação retinal | |
| UY36732A (es) | Piridin pirazinonas novedosas como inhibidores de bromodominios de la familia bet |